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Obesity has been suggested to have a detrimental impact on
kidney structure and function, leading to focal
glomerulosclerosis and hypertension. It is also associated
with hyperleptinemia and elevated renal sympathetic nerve
activity. Prenatal undernutrition promotes postnatal obesity,
hypertension, and an altered renal structure and function. In
this study, we examined the effects of prenatal nutrient
restriction and juvenile obesity in sheep. We found that
juvenile obesity led to chronic hyperleptinemia and reduced
renal function as assessed by nuclear scintigraphy. Additional
factors include hypertension, glomerulosclerosis, and
increased kidney apoptosis. Prenatal undernutrition,
synchronous with early kidney development, coupled
postnatally with juvenile obesity had no effect on systemic
pathophysiological sequalae associated with obesity per se.
Hypertension, hyperleptinemia, and poor renal function were
all observed in this group. All indices of renal pathology such
as increased expression of proinflammatory cytokines,
angiotensin II, glucocorticoid receptors, and increased
apoptosis and glomerulosclerosis were entirely absent in
obese prenatally undernourished offspring. Our data indicate
that juvenile obesity per se leads to systemic hypertension
and renal structural and functional pathology. Prenatal
undernutrition effectively abolishes any renal histopathology
associated with juvenile obesity.
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The incidence of obesity (body mass index 430 kg/m3) in
the UK and worldwide has increased markedly over the past
two decades.1 As obesity is a risk factor for many pathologies,
the incidence of a multitude of obesity-related diseases has
paralleled this increase1 including renal and cardiovascular
disease, for which systemic hypertension is a significant risk
factor.2 A specific reduction in body-fat mass ameliorates
both renal disease3 and hypertension,1 thus as obesity levels
continue to rise it is possible that there will also be a parallel
increase in renal disease over the next decade.3,2 Indeed,
obesity-related glomerulopathy, characterized by glomeru-
lomegaly and focal segmental glomerulosclerosis, has been
described as an ‘emerging epidemic’.4 Early work in obesity-
prone animal models predicted such renal-specific con-
sequences of excess body-fat mass.5
The mechanism(s) that underpins obesity-related renal
pathology has not been clearly delineated as obesity is often
associated with hypertension, which will independently exacer-
bate renal disease.2 However, Haynes6 has produced a body of
work implicating leptin as central to the inter-relationship
between obesity, hypertension, and the kidney. Elevated body-
fat mass leads to increased circulating leptin concentration,7,8
which elevates sympathetic nervous system activity producing
increases in blood pressure.6,9,10 Importantly, selective leptin
resistance appears to develop with obesity,11 that is preservation
of sympathetic effects but downregulation of metabolic effects,
with specific increases in the sympathetic tone to the kidney.8
Such an observation may, in part, explain a proportion of the
increased incidence of renal disease with obesity. In addition, a
direct mechanical contribution of increased perirenal adipose
tissue in obese animals may serve to increase intrarenal
pressure,12 exacerbating the hypertensive state and inducing
further progressive renal damage. Other locally produced
cytokines from perirenal adipose, in addition to leptin, may
also have direct effects on the kidney and accentuate obesity-
related glomerulosclerosis such as interleukin-6 and tumor
necrosis factor (TNF)-a as obesity per se has been described as a
proinflammatory state.13 Nevertheless, it is important to bear
in mind that not all obese people suffer renal disease and it is
highly possible that many other factors increase an individual’s
susceptibility to renal disease.
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One of these other factors may be the maternal
environment. Mackenzie and Brenner14 first suggested that
a reduction in nephron number was causal for the
development of essential hypertension. In support of this
concept, Keller et al.15 noted fewer glomeruli per kidney
(using three-dimensional stereology) from patients with
hypertension compared with normotensive controls. Re-
duced maternal nutrition in animal models has been shown
to lower the nephron complement of the offspring at birth
and in adulthood.16,17 In addition, babies born of low birth
weight have fewer nephrons (see Mackenzie and Brenner14)
and are subsequently at a greater risk of developing
hypertension as adults (reviewed in Zandi-Nejad et al.18).
Combined, these studies indicate that permanent changes in
renal structure can accompany maternal undernutrition
(which, depending on timing, can lead to low birth-weight)
especially if the period of nutritional restriction occurs in
synchrony with fetal nephrogenesis and therefore may
potentially be key towards the ‘programming’ of renovascular
hypertension. Further animal studies have been broadly
supportive of a structural and molecular programming by
maternal diet of the kidney,19,20 but although reduced
nephron number may have a role18 it is not the causal
link.21,22
In the sheep, the ovine pronephros develops and then
degenerates by day 35 of gestation (termB145 days), around
the time of implantation (days 18–30).23,24 The subsequent
mesonephros is partially functional at this time but regresses
by day 57–60. The mature ovine kidney (i.e., metanephros)
develops over days 27–110 and comprises a mass of
metanephric mesenchyme into which the ureteric bud grows
and branches, forming new nephrons until Bday 110 when
the full mature nephron complement is completed.25 In three
separate studies in the sheep, we have implemented maternal
nutrient restriction during 0–30 days,26 30–80 days,16 or 0–95
days gestation27 and measured resting blood pressure on each
occasion. Blood pressure was significantly elevated in only
the latter study, which spanned the majority of nephrogenesis
in the sheep. However, we cannot exclude an age-related
interaction with the prenatal diet as this study was conducted
on significantly older sheep (3 years) compared with the
other two studies (1 year26 and 6 months16). Nevertheless,
after maternal nutrient restriction from 30–80 days gestation,
offspring exhibited increased renal mRNA abundance for the
glucocorticoid receptor (GCR) and angiotensin-II receptor,20
possible early indicators of later, age-related renal dysfunc-
tion.
Clearly, both maternal nutritional exposure and obesity
per se can significantly influence the development of the
kidney and its function, respectively. One may hypothesize,
therefore, that prenatal undernutrition coupled with post-
natal obesity specifically exacerbates renal dysfunction and
glomerulopathy leading to an early onset of hypertension.
However, no study to date has examined any interaction
between these two factors. Hence, in this study the combined
effects of prenatal nutrient restriction with juvenile obesity
was examined with adult end points being (1) plasma leptin
concentration, (2) in vivo renal function, as assessed by
radionuclide renography, (3) resting systolic and diastolic
blood pressure, (4) key molecular markers within the kidney
cortex for apoptosis (terminal deoxynucleotidyl transferase-
mediated dUTP nick end-labelling (TUNEL) assay and
caspase-3 mRNA expression), glomerulosclerosis (periodic
acid Schiff ’s staining) and severe proteinuria (tubular protein
casts; commonly observed in cases of progressive renal
disease28,29), and (5) renal endocrine sensitivity, that is
mRNA for glucocorticoid and angiotensin-II receptors
(angiotensin II receptor type 1 (AT1) and angiotensin II
receptor type 2 (AT2) and TNF-a) at 1 year of age in sheep.
RESULTS
Physical activity and food intake
From weaning to 12 months of age, the restricted space
offered barn-housed groups of sheep resulted in a significant
(Po0.001) reduction in their average daily activity (obese
control (OC), 115 674711 593 and obese nutrient restricted
(ONR), 100 92777 189 accelerometry units) compared with
the relatively unrestricted field environment (lean control
(LC), 307 957751 598 accelerometry units). Over this time,
average daily food intake of individuals was also significantly
higher in barn-housed sheep (6 months: OC and ONR,
21.671.8 vs LC, 16.572.0 MJ/day). At 12 months of age, at
the time of renal and cardiovascular assessments the 24 h feed
intake of OC and ONR sheep had reduced such that daily
energy intake was not different from LC (OC, 15.971.3;
ONR, 15.071.0 vs LC, 15.671.3 MJ/day).
Blood pressure and heart rate
Baseline systolic (OC, 11673; ONR, 11973; vs LC,
10572 mm Hg) and diastolic (OC, 88.672.3; ONR,
86.072.2; vs LC, 78.171.5 mm Hg) blood pressures were
significantly (P¼ 0.04 and 0.02, respectively) higher in obese
relative to lean sheep. In addition, heart rate was also
significantly elevated in obese sheep (OC, 9872; ONR, 9873
vs LC, 8971 beats/min; P¼ 0.01).
Blood electrolytes, blood volume, plasma volume and leptin
concentration
Obese sheep had elevated blood glucose and calcium
concentrations relative to lean sheep (Table 1). No other
measured variable differed in obese sheep. Estimated blood
volume and plasma volume when corrected to lean body
mass (ml/kg lean mass) were significantly less in obese groups
(blood volume: OC, 135711; ONR, 146714; vs LC,
195715; P¼ 0.01 and plasma volume: OC, 8577; ONR,
9379; vs LC, 129710; P¼ 0.006). Hematocrit tended
toward higher values in obese sheep, but this was not
statistically significant (OC, 35.471.8; ONR, 37.271.3; vs
LC, 33.771.3). Leptin concentration was significantly
elevated in all obese relative to lean sheep (OC, 20.172.6;
ONR, 23.172.0; vs LC, 2.170.2 L; P¼ 0.0001). In addition,
plasma leptin was similar to these LC sheep in all lean
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nutrient-restricted offspring sampled at both 6 months and 3
years of age (data not shown).
Renography and glomerular filtration rate
The height of the left renogram curve in all sheep was
significantly lower than that of the right curve, reflecting the
attenuation of the g rays owing to the deeper abdominal
position of the left kidney vs the right kidney relative to the
camera head. For the left and right kidney, the time to peak
was 39 and 23% (left), 37 and 42% (right) longer in OC and
ONR, respectively, relative to LC, but the effect was not
statistically significant (Figure 1a). Both the upslope and
downslope of the renogram, however, were significantly
blunted in both of the obese groups in both kidneys (OC and
ONR) relative to the LCs (LV; Figure 1b and c). Nevertheless,
absolute glomerular filtration rate (GFR) tended (P¼ 0.08)
to be higher in obese sheep (OC and ONR) relative to lean
(LC) but when normalized to lean body mass tended to be
lower (P¼ 0.07; Table 2).
Body composition
At 12 months of age both OC and ONR sheep were
significantly heavier than LC (Table 3). Excluding the carcass,
the wet weight of all organs, with the exception of the
pancreas and lungs, was significantly heavier in obese relative
to lean sheep (OC and ONR vs LC; Table 3). In particular, the
left, but not right, ventricle and septum were significantly
enlarged in obese (OC and ONR) groups relative to LC.
However, when expressed relative to body weight, the brain,
heart, lungs, and pancreas were significantly smaller in OC
and ONR relative to LC (Table 3). The spleen was relatively
small when compared with LC, in OC only. As expected, total
visceral fat mass was also significantly elevated in obese sheep
(15.170.5 and 13.670.59 kg in OC and ONR, respectively,
vs LC, 5.070.5 kg; Po0.001). Carcass composition analysis
(excluding all wool and viscera) indicated significantly
increased adiposity (4672 and 4971% in OC and ONR,
respectively, vs 2472% in LC; Po0.001), significantly
reduced moisture content (38.371.6 and 36.471.3% in
OC and ONR, respectively, vs 53.671.6% in LC; Po0.001),
and significantly reduced protein content (N*6.25; 11.570.4
and 10.770.3 kg in OC and ONR, respectively, vs LC,
16.870.6 kg) in obese vs lean sheep. Thus, lean body mass
(body weight–total fat mass) expressed on a dry weight basis
(lean body mass–moisture) was significantly greater in obese
vs lean sheep (38.970.8 and 36.573.1 kg in OC and ONR,
respectively, vs 22.971.8 kg in LC; Po0.001).
Glomerulosclerosis, protein casts and renal expression
of GCR, AT1, AT2, and TNF-a
Glomerulosclerosis was significantly increased in OC relative
to both LC and ONR (Po0.001 for both cases; Figure 2a–c)
Table 1 | Blood metabolites and electrolytes in lean and
obese sheep
LC OC ONR P
Glucose (mmol/l) 3.4070.17 4.2170.19* 4.1170.15* 0.001
Lactate (mmol/l) 1.8370.46 2.0370.47 2.6470.20 NS
Ca+ (mmol/l) 1.1570.05 1.2970.01* 1.2770.01* 0.001
K+ (mmol/l) 4.0870.08 3.9370.05 3.8770.11 NS
Cl- (mmol/l) 10570.30 10570.70 10670.43 NS
Hemoglobin (g/dl) 14.170.4 13.570.8 14.870.6 NS
LC, lean controls (n=8); OC, obese controls (n=8); ONR, obese nutrient restricted
(n=11); NS, not significant.
Statistics are; *Po0.01 LC vs OC and ONR.
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Figure 1 | The effect of obesity on in vivo renal function as
assessed with radionuclide renography. Data are expressed as
mean7s.e.m. for LC (n¼ 6), OCs (n¼ 8), and ONR (n¼ 4).
(a) Time to peak (min) is from bolus injection of technetium-
99–diethylenetriaminepentaaceticacid to peak counts in the right
kidney; (b) The upslope is defined, for the right kidney, as the positive
slope of the renogram occurring before the peak and computed
using the X and Y values of the renogram at 5 and 90% of the peak Y;
(c) The downslope is defined, for the right kidney, as the negative
slope of the renogram occurring after the peak and computed using
the X and Y values of the renogram at the peak and at the half-peak
value on the downslope side of the curve. *Po0.05, OC and ONR vs LC.
Table 2 | Glomerular filtration rate in lean and obese sheep
LC OC ONR P
GFR (ml/min) 93.579.9 138715 114717 0.08
GFR (ml/min/g kidney) 0.8470.09 0.8170.06 0.6870.07 NS
GFR (ml/min/kg lean mass) 4.0270.30 3.2470.27 3.1170.59 0.07
GFR, glomerular filtration rate; LC, lean controls (n=6); OC, obese controls (n=8);
ONR, obese nutrient restricted (n=4); NS, not significant.
Glomerular filtration rate as assessed using technetium-99–diethylenetriaminepenta-
acetic acid. See Materials and Methods for details.
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and protein casts were evident in OC only (data not shown).
In addition, OC kidneys had significantly increased expres-
sion of GCR (Figure 3a), AT1 (Figure 3b), TNF-a (Figure 3c),
and AT2 (OC, 3.5970.6; ONR, 1.7270.36; vs LC,
1.2970.31 106 AT2/18S; LC vs OC P¼ 0.0001) relative
to ONR and LC.
No evidence of glomerulosclerosis or luminal protein casts
were found in all kidney sections from either control or
nutrient-restricted offspring that did not become obese
postnatally, when sampled at 3 years of age (data not
shown). Similarly, there was no significant difference in
mRNA abundance for GCR, AT1, AT2, or TNF-a between
kidneys of these control and nutrient-restricted offspring
(e.g., at 6 months of age GCR: C 0.5170.28; NR 0.337
0.16 103 GCR/18S; AT1: C 0.6370.21; NR 0.6970.19
 106 AT1/18S; AT2: C 0.5670.31; NR 0.6870.26 106
AT2/18S; TNF-a: C 0.4570.17; NR 0.1870.08 107
TNF-a/18S).
Index of renal apoptosis: TUNEL and caspase 3 labelling
The proportion of TUNEL-positive cells was higher in the
renal medulla vs cortex for all nutritional groups (Figure 4a).
However, there was a markedly higher proportion of
TUNEL-positive cells in both the renal cortex and medulla
in OC relative to LC and ONR (Po0.001 for both cases;
Figure 4a). A similar pattern emerged when using caspase 3
immunostaining for apoptosis, higher levels in the medulla vs
cortex and significantly increased (P¼ 0.01) staining in OC
vs both LC and ONR (Figure 4b). Again, in lean nutrient-
restricted and control animals (i.e., not subjected to juvenile
obesity) there was no evidence of apoptosis in any of the
kidneys examined from either control or nutrient-restricted
offspring at 3 years of age (data not shown).
DISCUSSION
Juvenile sheep exposed to an environment that promotes
physical inactivity and increased food intake rapidly become
obese and exhibit hypertension as young adults, regardless of
prenatal diet. These obese, hyperglycemic, hyperleptinemic
young adult sheep also display reduced renal uptake of
technetium-99–diethylenetriaminepentaacetic acid and
blunted intrarenal passage of the tracer, indicating reduced
renal functional capacity. In these obese sheep, marked renal
histopathology was also present as indicated by increased
cortical apoptosis, glomerulosclerosis, luminal protein casts,
and increased renal expression of GCR, AT1, and TNF-a;
combined, the data suggest a propensity for a rapid age-
related decline in renal function with obesity. Juvenile obesity
per se is particularly indicated given no evidence of renal
pathology in any animal that did not become obese
postnatally. Surprisingly, prenatal undernutrition during the
major period of nephrogenesis in the sheep (group ONR)
prevented all of the obesity-induced renal histopathological
changes, but did not alter the systemic dysfunction;
hypertension, blunted renograms, and elevated blood cal-
cium were all similar to OCs. The data indicate a particularly
deleterious effect of juvenile obesity on renal function that is
associated with hypertension and renal histopathology by 1
year of age, but a surprising ‘protective’ effect of prenatal
undernutrition on renal histopathology only.
In this study, the level of obesity or increased fat mass was
significant, being 47% of the carcass weight in the sheep as
compared with 22% in controls. In human terms, these sheep
were certainly in the obese body mass index category (430 g/
m3). It is of note however, that this degree of obesity was
produced primarily through a restriction of spontaneous
physical activity rather than gross overfeeding during a
period (adolescence) when such activity would be expected.
The LC sheep allowed greater space for activity, expended
B3.5-fold more energy engaged in low-moderate activity,
but only ate 25% less food than the obese sheep over this
time. By 12 months of age, however, food intake was similar
between all groups but the overweight individuals remained
relatively physically inactive, even in an equivalent environ-
ment as the LCs (data not shown). Thus, the obese groups, as
young adults, remain susceptible to further weight gain. This
perhaps reflects a consequence of increased body weight and/
or is a latent effect of a physically inactive adolescence, but
nevertheless perpetuates the deleterious effects of excess
adiposity acquired during early life.
Plasma leptin is known to increase with increased
adiposity30 and in this study the levels of leptin were B10-
fold greater in the obese sheep at 1 year of age. Concurrent
with the increase in leptin was a higher resting blood
concentration of glucose (4.2 vs 3.4 mM) and calcium (B1.28
vs 1.15 mM) in obese vs lean individuals. Resting hypergly-
cemia is indicative of global insulin resistance and developing
type II diabetes can induce diabetic nephropathy, leading, in
theory, to altered renal calcium handling.31 Elevated plasma
calcium has been observed in morbidly obese patients with
Table 3 | Absolute and relative organ weights in lean and
obese sheep
LC OC ONR P
Body weight (kg) 58.6792.4 88.772.6* 85.871.5* 0.001
Brain (g) 10473 8973* 9372* 0.005
Kidney (g) 11779 15577* 16477* 0.001
Liver (g) 602736 897759* 875750* 0.001
Spleen (g) 10279 92716 163727 0.07
Lungs (g) 567744 508734 505730 NS
Pancreas (g) 53.073.4 60.276.3 62.474.4 NS
Heart (g) 237710 309712* 271716 0.02
Left ventricle (mm) 13.572.1 21.172.4* 19.571.4* 0.02
Right ventricle (mm) 6.371.1 6.471.5 7.271.1 NS
Septum (mm) 13.571.9 19.871.1* 20.771.3* 0.004
Brain:body (g/kg) 1.8470.13 0.9970.04* 1.0770.02* 0.001
Kidney:body (g/kg) 2.0470.14 1.7170.04 1.8770.10 NS
Liver:body (g/kg) 10.470.3 9.970.6 10.270.5 NS
Spleen:body (g/kg) 1.7770.13 1.0270.18* 1.7870.31 0.01
Lungs:body (g/kg) 9.8370.52 5.5970.31* 5.7870.41* 0.001
Pancreas:body (g/kg) 0.9370.06 0.6670.06* 0.7270.06* 0.01
Heart:body (g/kg) 4.1570.12 3.4270.13* 3.0770.19* 0.001
LC, lean controls (n=8); OC, obese controls (n=8); ONR, obese nutrient restricted
(n=11).
Statistics are *Po0.05 LC vs OC and/or ONR.
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hyperparathyroidism32 and although parathyroid hormone
levels were not measured in this study it is possible that a
similar clinical state exists in the obese sheep, leading to the
observed increases in resting plasma [Ca2þ ]. Certainly, the
coexistence of hypertension with hyperleptinemia and altered
glucose and calcium handling in the obese animals will
exacerbate any age-related decline in renal functional
capacity.33 It is of note that this is the first study to generate
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Figure 2 | Glomerulosclerosis in obese sheep. (a) The effect of prenatal nutrient restriction and postnatal obesity on renal glomerulosclerosis
score as assessed by periodic acid Schiff’s staining (see Materials and Methods for details). Data are expressed as mean7s.e.m. for LCs (n¼ 8),
OCs (n¼ 8), and ONR (n¼ 11). Statistics are *, Po0.01 OC vs LC and ONR. Photographs depicting the degree of glomerulosclerosis as assessed
through periodic acid Schiff’s staining at original magnification  200. (b) OC, (c) ONR, (d) LC. Arrows indicate areas of glomerulosclerosis,
which were significantly more prevalent in OC vs ONR and LC (Po0.01).
Table 4 | Primers sequences and optimal PCR conditions used
Gene Primer sequence Annealing temp (1C) Product size (bp) Refs.
GCR Forward 50-ACTGCCCCAAGTGAAAACAGA-30 59.0 150 53
Reverse 50-ATGAACAGAAATGGCAGACATT-30
AT1 Forward 5
0-GGGCTGTCTACACTGCTATGGAA-30 60.0 67 54
Reverse 50-CCGGAAGCGATCTTACATAGGTA
AT2 Forward 5
0-TGTTCTGGCGTTCATCATTTG-30 60.0 71 54
Reverse 50-CCATCCAAGCTAGAGCATCCA-30
TNF-a Forward 50-GGTGCCTCAGCCTCTTCTC-30 60 136 55
Forward 50-GAACCAGAGGCCTGTTGAAG-30
18s Forward 50-ATGCGGCGGCGTTATTCC-30 56.0 125 53
Reverse 50-CTCCTGGTGGTGCCCTTCC-30
AT1, angiotensin II receptor type 1; AT2, angiotensin II receptor type 2; GCR, glucocorticoid receptor; TNF, tumor necrosis factor.
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significantly hypertensive sheep (i.e., an increase of
B10–15 mm Hg) at 1 year of age, virtually entirely through
acquisition of excess body-fat mass during adolescence and
young adulthood. There was no interaction with the prenatal
diet on the degree of hypertension observed as a young adult
in this study, in contrast to previous data in non-obese
laboratory species.34
It has been suggested that, together with metabolic
abnormalities, elevated production of the protein products
of adipose tissue including leptin, adipokines, and angio-
tensinogen, for example, contribute significantly toward the
progression of end-stage renal disease.33 In the OCs of this
study, leptin was indeed markedly increased as was the renal
expression of GCR, TNF-a, and AT1, indicating the potential
for enhanced GC sensitivity, local proinflammatory cytokine
activity, and local vasoconstriction, respectively. Taken
together, it is envisaged that the OCs of this study would
indeed be susceptible to obesity-induced renal failure.
Increased renal angiotensin II sensitivity (reflected by
increased AT1 in OC, but not ONR or LC) may well
underpin the increased renal apoptosis and widespread
pathology observed, as has been shown in rats.35 However,
prenatal nutrient restriction occurring synchronous with
nephrogenesis prevented all local molecular changes and any
signs of regional apoptosis, glomerulosclerosis, or presence of
protein casts despite similarly high plasma leptin, plasma
calcium, and blood pressure as OCs. Parallel changes between
the AT1 and AT2 receptors have been reported previously in
several injury models,36 but in this study prenatal under-
nutrition dissociated this effect and prevented the pathology
from occurring. Thus, in this study, it would appear that for
the early signs of renal failure to develop in the face of high
plasma leptin and hypertension, the local molecular changes
within the kidney (increased GC sensitivity, proinflammatory
cytokine activity, and AT1-mediated vasoconstriction) are a
prerequisite. One further explanation as to why the kidneys
of offspring born to nutrient-restricted mothers are less
susceptible to apoptosis may be related to increased insulin-
like growth factor-I receptor abundance37 that would be
1400
1200
1000
800
600
400
200
0
∗
∗
∗
4.0
4.0
4.5
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0.0
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0.0
LC OC ONR
a
b
c
G
CR
/1
8s
 ×
 
10
−
5 
AT
1/
18
s 
×
 
10
−
6 
TN
F
/1
8s
 ×
 
10
−
7 
Figure 3 | Data are expressed as mean7s.e.m. The effect of
prenatal nutrient restriction and postnatal obesity on renal
expression of (a) GCR, (b) AT1, and (c) TNF-a. All data are expressed as
a ratio to 18s concentration. LC (n¼ 8), OC (n¼ 8), and ONR (n¼ 11).
Statistics are *Po0.01 OC vs LC and ONR.
5.0
TU
NE
L 
+
ve
 
(m
ea
n s
co
re)
Ca
sp
as
e 
+
ve
 
(m
ea
n c
ou
nt/
fie
ld)
4.0
3.0
2.0
1.0
0.0
400
350
300
250
200
150
100
LC OC ONR
∗
∗
∗
∗
∗
†
†
†
†
Figure 4 | The effect of prenatal nutrient restriction and postnatal
obesity on renal apoptosis in the cortex (solid bars) or medulla
(hatched bars) as assessed by TUNEL (data expressed as mean
semiquantitative grading score7s.e.m.) or caspase-3
immunolabelling (data expressed as mean positive cell count per
original magnification 200 field7s.e.m.). LCs (n¼ 8), OCs (n¼ 8),
and ONR (n¼ 11). Statistics are *Po0.05, cortex vs medulla; wPo0.01
OC vs LC and ONR.
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predicted to promote cell survival38 rather than apoptosis.
The extent to which apoptosis precedes the kidney damage
we have described, however, remains to be established.
Hypertension is twice as common in overweight vs
average-sized individuals1 although the precise relationship
between obesity and cardiovascular control is not fully
understood. Clearly, excess body mass places a greater burden
on the heart, which is unable to fully compensate (i.e.,
proportionately enlarge) in the way other metabolic organs
do (e.g., liver, kidney). Thus, left ventricular hypertrophy
develops to generate the greater force needed to effectively
perfuse the greater body mass, as reproduced in this study.
Extrapolating from these observations, an increased left
ventricular mass will reduce intraventricular volume, redu-
cing stroke volume and thus increased heart rate is necessary
to maintain cardiac output. The obese groups in this study
had elevated resting heart rate and this most probably reflects
either increased sympathetic sensitivity to extrinsic stimuli or
greater autonomically driven sympathetic tone. Although this
study cannot isolate which of these influences predominates,
it is of note to consider the volume of data generated by
Haynes, Mark, and co-workers with regard to the effect high-
circulating plasma leptin has on sympathetic activity,8–11,39
specifically on the sympathetic output to the kidney.2,10,12
Indeed, it has been shown that renal denervation prevents
obesity-induced hypertension.40
Thus, the theoretical ontogeny of obesity-related hyper-
tension in this study may be hypothesized as follows: gradual
acquisition of excess body fat throughout adolescence leads
to greater production of leptin and gradual leptin resistance.
The elevated plasma leptin specifically activates sympathetic
activity, in particular the renal branch,12 and together with
the greater demand that excess body weight places on the
heart leads to hypertension. High blood pressure, high leptin,
and increased renal sympathetic activity gradually progress
the kidney toward early-stage renal failure, characterized by
cortical nephron apoptosis and glomerulosclerosis. These
end-stage processes are exacerbated by, and dependent on,
concurrently increased local glucocorticoid, renin–angio-
tensin system, and inflammatory processes. Prenatal nutri-
tional restriction during nephrogenesis, although limiting
total nephron number in many studies41–43 stimulating single
nephron hypertrophy and hyperfiltration, in this study at
least, prevents or perhaps only delays the end-stage renal
pathology observed in OC animals.
In conclusion, we have demonstrated for the first time, in
a large animal species, significant early life hypertension and
early indices of renal failure that are entirely related to excess
adiposity acquired during adolescence. Demonstrable indices
of end-stage renal failure such as increased cortical apoptosis,
glomerulosclerosis, and presence of protein casts only occur
if the above clinical symptoms are concurrent with increased
expression of renal glucocorticoid, renin–angiotensin, and
inflammatory markers. Prenatal undernutrition prevents
increased expression of these markers in the kidney and
prevents the early development of renal apoptosis and
glomerulosclerosis despite being similarly hyperleptinemic,
hyperglycemic, and hypercalcemic at 1 year of age. Whether
the pathological renal sequalae of juvenile–adult obesity are
simply postponed to later in life in prenatally programmed
animals cannot be determined, but certainly obesity per se is
strongly contraindicated with respect to maintaining normal
renal function and avoiding renal disease.
MATERIALS AND METHODS
Animals and experimental design
All procedures were performed in accordance with the UK animals
(Scientific Procedures) Act, 1986. At day 30 of gestation, 26 Welsh
Mountain ewes were randomly allocated to receive either a control
(C; 7 MJ/day: n¼ 16) or nutrient-restricted diet (NR; 50% of C,
n¼ 11) until day 80 of gestation. Thereafter, all sheep were fed 100%
calculated metabolizable energy requirements to term (12–13 MJ/
day near term).44 Offspring were delivered spontaneously and were
reared by their mothers to weaning (10 weeks). After birth, all
mothers were fed a diet of hay ad libitum together with a fixed
amount of concentrate pellets sufficient to fully meet their own
metabolizable requirements, plus that needed to maintain lactation.
All diets contained adequate minerals and vitamins. From weaning
to 12 months of age, offspring were either group-housed in a barn
(restricted activity), at a stocking rate of 17 animals per 50 m2 with
ad lib access to hay and concentrate pellets to promote increased fat
deposition (OC, n¼ 8; ONR, n¼ 11) or pasture grazed at a stocking
rate of 17 animals per 3000 m2 (unrestricted activity; LC, n¼ 8) with
ad lib access to grass and concentrate pellets. Over this time the gross
metabolic budget (energy expenditure vs energy intake) of all sheep
was assessed as follows: energy expenditure by measurement of low-
moderate physical activity with accelerometry (‘Actiwatch’, Linton
Instrumentation, Diss, UK) and energy intake as total food intake
over a 24-h period. For energy expenditure, an unaxial acceler-
ometer was attached to a collar on the sheep perpendicular to the
plane of forward movement and a record logged every 30 sec for a
24-h period. Data were then downloaded to an Excel spreadsheet for
further analysis. Activity data reflected 5760 data points in total for
each individual sheep.
At 1 year of age, that is as young adults, all sheep were group-
housed indoors for 1 week before surgical implantation of arterial
and venous catheters. Over this time both energy expenditure and
energy intake were again assessed. All food, but not water, was
withdrawn from the animals for 24 h before surgery. Anesthesia was
induced with propofol (rapinovet; 6 mg/kg) and maintained with
3–4% isoflurane in O2 3–4 l/min. Carotid and jugular catheters were
inserted into each sheep and the incision closed. All sheep received a
course of antibiotic (10 mg/kg intramuscularly procaine penicillin,
‘duphapen’; Fort Dodge Animal Health Ltd, Southampton, UK) and
analgesia (2 mg/kg intramuscularly flunixin meglumine; ‘finadyne’;
Schering-Plough, Kenilworth, UK) for 3 days postoperatively.
Catheter patency was maintained by daily flushing with heparinized
saline (50 IU heparin/ml). All sheep had established normal feeding
patterns within 0.5–1 h after surgery and showed no visible signs of
discomfort for the duration of the experimental period.
Additional groups of control and early-mid gestational nutrient-
restricted sheep were also used to investigate the impact of nutrient
restriction on molecular and histological effects on the kidney. These
included 12 sheep of the same age and breed and fed the same diets
as described above. Six of the 12 animals were nutrient restricted
between 28–80 days gestation and six were fed a control diet. All
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offspring were born normally at term and each remained with their
mother until 10 weeks of age. The offspring were then reared out at
pasture under environmental conditions that were identical to that
described for the LCs above, that is forming a ‘lean nutrient
restricted’ group. All offspring were then tissue sampled (6 months)
after birth for which molecular results from the lung have already
been published.45 In addition, renal tissue from a further group
(n¼ 10) of lean nutrient-restricted (from 0–95 days gestation)
offspring were sampled at 3 years of age for which hepatic molecular
data have been published.46
Experimental protocols
In vivo experiments. Blood sampling and blood volume
measurement: A period of 2–4 days postoperative recovery was
allowed and the investigator was blinded to the dietary origin of the
sheep before any experiment was performed. A baseline blood
sample of 10 ml was taken from the jugular cannula of all offspring.
A proportion of this blood was used to assess basal metabolites and
electrolytes (blood glucose, lactate, hematocrit, and blood [Ca2þ ],
[Kþ ], [Cl]). Following this, the sheep were injected with 5 ml
Evans blue solution (3 mg/ml) and a blood sample (5 ml) collected
exactly 15 min later.47 All blood was centrifuged at 3000 r.p.m. for
10 min and plasma decanted. Blood volume was calculated by
measuring the concentration in 200 ml plasma against the indivi-
dual’s standard curve (0–20 mg/l Evans blue in 200ml plasma) using
the baseline sample on a 96-well plate reader.
Blood pressure: Sheep were habituated to a metabolic crate and
after at least an hour the arterial catheter was connected to
precalibrated pressure transducers (SensorNor 840; S 4925) attached
at heart level linked to a data acquisition system (Po-Ne-Mah;
Version 3, Gould Instrument Systems Inc., LDS Test and Measure-
ment Ltd, Royston, Herts, UK) and a baseline recording taken over a
further hour. Analogue signals for real-time systolic, diastolic, mean
arterial pressure, and heart rate were recorded at 1-sec intervals,
digitized, and then stored on an Excel spreadsheet for further
analysis.26
Renal scintigraphy and GFR: On a separate day, a proportion
(n¼ 18) of the offspring comprising LC (n¼ 6), OC (n¼ 8), and
ONR (n¼ 4) were individually placed in a metabolic crate but
directly under a g-camera head that was positioned horizontally above
their kidneys. At time 0, 100 MBq technetium-99–diethylenetriami-
nepentaacetic acid (diethylenetriaminepentaaceticacid which is
cleared only through the kidneys) in 0.5 ml NaCl was injected
intravenously. Over the next 20 min, an image was captured on the g
camera every 20 s, producing a total of 60 frames from which a
dynamic renogram was produced for each kidney that was
automatically adjusted for background correction and bolus dose
deconvolution and manually corrected post hoc for movement
artifact.48 Specific measures of interest were time to peak (min) and
upslope (cpm) – indicative of rate of uptake of tracer into the kidney,
downslope (cpm) – indicative of rate of tracer clearance and area
under the curve – reflecting the summated renal function curve. At 3,
4, and 5 h later, 5 ml blood was drawn from the contralateral jugular
cannula into heparinized tubes and plasma collected for measurement
of GFR. In brief, duplicate 1 ml plasma aliquots, with timed control
samples, were counted on a g counter and GFR determined by
extrapolation from the decline in blood radioactivity over time.48–50
After all experiments, the sheep were humanely killed by
electrocortical stunning and exsanguination. All major organs were
rapidly excised, weighed, and a representative sample snap-frozen in
liquid nitrogen before being stored at 801C until further molecular
analysis was performed. Additionally, a representative mid-line
section of kidney was dissected (B10 g), fixed in 10% (v/v)
formalin, and embedded in paraffin wax for subsequent histological
analysis as described previously.16 For body composition analysis,
the wool was removed and the carcass sectioned down the midline
with a half-carcass being minced. A proportion (500 g) was analyzed
chemically (Eurofins Laboratories Ltd, Wolverhampton, UK) for
moisture content, percentage protein (Kjedahl method 6.25; i.e.,
total non-fat mass), and total fat (Soxhlot method).
Molecular biological analyses
Leptin assay. Plasma leptin concentration was determined using a
validated double-antibody regulatory impact analysis as previously
published.51 Plasma concentrations of leptin were assayed in
duplicate 200 ml samples using a rabbit anti-ovine leptin primary
antibody, iodinated ovine leptin, and sheep anti-rabbit secondary
antibody. The limit of leptin detection was 0.1 ng/ml and the intra-
and interassay coefficients of variation for the assay were 4.2 and
9.1%, respectively.
Preparation of mRNA. Total RNA was extracted from a known
amount of kidney tissue (between 50–100 mg) using Tri-reagent
(Sigma, Poole, UK). Following RNA extraction, 1 mg of each sample
was reverse transcribed in a 20ml reaction containing buffer (250 mM
Tris–HCL, 40 mM MgCl2, 150 mM KCL, 5 mM dithioerythritol; pH
8.5), 2 mM deoxyribonucleotide triphosphates, 1 hexanucleotide
mix, 10 U RNase inhibitor, 10 U reverse transcriptase (RT) (Roche
Diagnostics, Lewes, UK) in a Touchgene Gradient thermocycler
(Techne, Barloworld Scientific Ltd, Stone, UK). The conditions used
to generate first strand cDNA were 721C (5 min), 41C (2 min), 251C
(5 min), 251C (10 min), 421C (60 min), and 721C (10 min). To
ensure that there was no contaminating genomic DNA control,
reactions without RT were included. RNA concentration and quality
were verified by gel electrophoresis and spectrophotometrically
using a standard conversion factor of one absorbance unit at 260 nm
per 40 mg RNA/ml. All samples had an A260/A280 ratio greater than
1.96. Total RNA concentration varied from 0.21 to 0.33 mg/ml among
all samples. RNA concentration was adjusted by dilution with
nuclease-free water (Ambion Applied Biosystems, Warrington, UK)
before cDNA synthesis to a standard concentration of 1 mg/ml. All
samples were stored at 201C until use.
Standard curve generation. Standards for GCR type II (GR),
AT1, AT2, TNF-a, and for the housekeeping gene 18s ribosomal RNA
were made from cDNA obtained from a randomly selected LC
animal kidney using semiquantitative polymerase chain reaction
(PCR). The method used oligonucleotide primers to GCR, AT1,
AT2, TNF-a, and 18s genes generating specific intron-spanning
products. 18s was chosen as the housekeeping gene as the
alternatives (e.g., glyceraldehyde-3-phosphate dehydrogenase and
b-actin) are nutritionally sensitive.52 The PCR program comprised
an initial denaturation stage (951C, 15 min), amplification (stage I,
941C (30 s); stage II, annealing temperature (30 s); stage III, 721C
(1 min), and final extension (721C, 7 min; 81C ‘hold’). The PCR
mixture (final volume 20 ml) contained 7 ml nuclease-free water
(Ambion), 10 ml thermo-start PCR master mix (50 ml contains
1.25 U Thermo-Start DNA polymerase, 1 thermo-start reaction
buffer, 1.5 mM MgCl2 and 0.2 mM each of denatured adenotripho-
sphate, denatured 20-deoxycytidine 50-triphosphate, denatured 20-
deoxyguanosine 50-triphosphate, and denatured 20-deoxythymidine
50-triphosphate (ABgene, Epsom, UK)), 1 ml forward primer, 1 ml
reverse primer, and 1 ml RT (cDNA) product. The annealing
temperature and cycle number of all primers were optimized and
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used in their linear range (Table 4). Agarose gel electrophoresis
(2.0–2.5%) and ethidium bromide staining confirmed the presence
of both the product and 18s at the expected sizes. All procedures
were performed with appropriate negative and positive controls as
well as a range of molecular weight markers (MBI Fermentas, York,
UK). The resultant PCR product was extracted (QIAquick gel
extraction kit, Qiagens, cat no. 28704), sequenced, and results
cross-referenced against the Genbank website to determine specifi-
city of the target gene. After confirmation that the product was
specific to the target gene, extracted PCR products were resuspended
in nuclease-free water and a 10-fold serial dilution performed.
Standards were stored at 201C until use in quantitative PCR.
Quantitative (real-time) PCR. Quantitative PCR was used to
examine the expression of GCR, AT1, AT2 TNF-a, and 18s (Table 4).
PCR reactions, set up in duplicate, were carried out in 20ml volumes
consisting of 1 SYBRs PCR mastermix (with ROX passive
reference dye) (Qiagen Ltd, Crawley, UK), 500 nM forward primer,
500 nM reverse primer, and 7 ml nuclease-free water. Real time PCR
was performed in a Techne QuanticaTM 14 real-time thermocycler
(Techne, Barloworld Scientific Ltd) on all samples at 951C (15 min)
followed by 45 cycles of 951C (15 s), annealing temperature (25 s),
721C (25 s). Three negative control reactions were carried out with
each set of samples analyzed: (1) no RNA template but RT and
polymerase provided; (2) RNA and polymerase provided but no RT;
and (3) RNA and RT provided but no polymerase.
Histological analysis. Serial sections of 5 mm were cut in the
same orientation from paraffin-embedded tissue blocks (Sledge
Microtome, Anglia Scientific, Norwich, UK) and mounted onto
Superfrost plus glass microscope slides (Menzel-Glaser, Braunsch-
weig, Germany). Sections were left to adhere to slides overnight at
371C. Before use, sections were dewaxed by immersion in xylene
followed by rehydration in descending concentrations of alcohol,
3 min each.
Periodic acid Schiff’s staining for glomerulosclerosis. Sections
were incubated in periodic acid 0.5% solution for 5 min (Merck,
Darmstadt, Germany), rinsed in running tap water and covered with
Schiff ’s reagent (Merck) for 15 min.56 Following rinsing in tap water,
sections were counterstained with Harris’s hematoxylin before
dehydration in ascending concentrations of alcohol. Glass coverslips
(VWR International, Lutterworth, Leicestershire, UK) were
mounted using DPX mountant (BDH, Poole, Dorset, UK).
Assessment of tubular injury from the presence of protein
casts. This technique was identical to that described by Xia et al.57
with the number of protein casts in the outer medulla of five
randomly selected fields being used to calculate the mean incidence
of protein casts (7s.e.m. per original magnification  200 field).
Detection of apoptosis with TUNEL and caspase 3 labelling.
TUNEL: The TUNEL assay (Roche Diagnostics, Manheim,
Germany) was carried out following the manufacturer’s protocol
for formalin-fixed paraffin-embedded tissues. The sections were
mounted using Vectashield mounting medium (Vector Laboratories,
Peterborough, UK) and covered with glass coverslips (VWR
International). The sections were stored at 41C in the dark and
were analyzed and photographed within 48 h. Two negative controls
were performed by replacing 50 ml of TUNEL reaction mixture with
50 ml of label solution (containing no terminal deoxynucleotidyl
transferase enzyme) in order to assess both nonspecific binding and
the extent of autofluorescence within the tissue section. Positive
controls were included, which were treated with deoxyribonuclease
type I to produce fragmentation of chromosomal DNA. The
deoxyribonuclease-positive control was washed separately to prevent
any residual deoxyribonuclease activity affecting other sections in
the assay.58
Caspase-3: As the TUNEL reaction is unable to discriminate
apoptotic from necrotic cells, caspase-3, a marker of early apoptosis
was localized using a rabbit anti-caspase 3 polyclonal antibody
(Abcam plc, Cambridge, UK) diluted 1:50. Immunohistochemistry
was performed on a commercially available computerized BondTM
automated immunohistochemistry system (Vision Biosystems
Limited, Newcastle-upon-Tyne, UK) using a bond polymer refine
detection kit. A negative control was performed for each test section
by omitting incubation in the primary antibody. Tonsil was used as
the positive control. Sections were dehydrated in ascending
concentrations of alcohol and xylene before coverslips were
mounted (DPX mountant, BDH).
Quantification of histological studies
TUNEL: All analysis was performed blind by the same assessor using
reference slides to check consistency of grading assessment. For
assessment of apoptosis, slides were analyzed using fluorescence
microscopy using fluorescein isothiocyanate and UV filters to
visualize green (fragmented DNA). A semiquantitative apoptosis
index (0–4) was derived from a previously described method.43
Grade 0¼ no positive labelling, 1¼ 1–25%, 2¼ 26–49%,
3¼ 50–74%, and 4¼ 75–100% of cells in nephron positively labelled.
All glomeruli and 30 randomly chosen fields in the medullary region
per kidney section were evaluated at original magnification  200.
Sclerosis: Sampled glomeruli were given a semiquantitative
sclerosis score between 0 and 4. Normal (no sclerosis) glomeruli
were representative of 0. Glomeruli with 1–25% sclerosis were
graded as 1, 26–50% as 2, 51–75% as 3, and 76–100% as 4.
Caspase-3: Quantitation was performed at original magnification
 200 using a 10 10 mm graticule. For each section, the number
of positive cells in five randomly selected fields was used to calculate
the mean positive cell count 7s.e.m. per original magnification
 200 field. To make a comparison of cell numbers within a similar
area of tissue, fields containing large vessels were not included as the
presence of these reduced the total tissue area in which cells could be
counted.
Statistical analysis
All data are presented as mean7s.e.m. Tests of normality as
determined by the Kolmogorov–Smirnoff test revealed that with the
exception of GCR, the data was parametric, thus statistically
significant differences between all groups were determined by one
way analysis of variance with post hoc comparisons to determine
individual differences between groups as appropriate. Bonferroni’s
correction was applied in order to adjust for the multiple tests
being performed. Data for GCR was analyzed by the Kruskal–Wallis
test to identify treatment differences followed by Mann–Whitney
U tests to determine individual difference between groups. Statistical
analysis was carried out using SPSS version 14 software (SPSS Inc.,
Chicago, IL).
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